Clinical Trial: Intra-Nasal Mechanical Stimulation (INMEST) as a Potential Preventative Treatment for Migraine

U.S., Dec. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07279623) titled 'Intra-Nasal Mechanical Stimulation (INMEST) as a Potential Preventative Treatment for Migraine' on Nov. 18.

Brief Summary: This is a prospective, randomized, open-label, delayed-start clinical investigation evaluating the safety and efficacy of the Walther System, a Class IIa investigational medical device delivering intra-nasal mechanical stimulation (INMEST), as a preventative treatment for migraine. A total of 110 adults (18-65 years) with a history of migraine will be randomized 1:1 into two groups: Group A (early treatment) and Group B (delayed treatment). The study includes baseline assessments, in-clinic device training, and ...